venBio Select Advisor holds $212.7 million of Sarepta stock.
Adage Capital Management holds $182.3 million
These elephants have deep knowledge of the challenges Sarepta faces re FDA efficacy queries.
They have large positions in Sarepta they need to protect.
No doubt Goolsbee will be key player going forward as the ANP story unfolds.
.
- Forums
- ASX - By Stock
- PER
- Ann: Positive preliminary results from ATL1102 DMD Phase II trial
Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-596
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
-0.002(2.30%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.7¢ | 8.7¢ | 8.3¢ | $82.04K | 969.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 200841 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 102187 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 200841 | 0.083 |
2 | 143500 | 0.081 |
2 | 106250 | 0.080 |
3 | 132078 | 0.079 |
2 | 120924 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 102187 | 2 |
0.087 | 429525 | 2 |
0.088 | 457142 | 2 |
0.089 | 295000 | 3 |
0.090 | 494374 | 5 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |